Document type: drug_safety_update
There are 847 pages with document type ‘drug_safety_update’ in the GOV.UK search index.
Rendering apps
This document type is rendered by:
Supertypes
| Type | Group |
|---|---|
| User journey | thing |
| Email document type | other |
| Government document type | other |
| Content Purpose Subgroup | updates_and_alerts |
| Content Purpose Supergroup | news_and_communications |
Content schemas
This document type is allowed by the schema:
Example pages
- GLP-1 receptor agonists: reminder of the potential side effects and to be aware of the potential for misuse
- Thiopurines and intrahepatic cholestasis of pregnancy
- Short-acting beta 2 agonists (SABA) (salbutamol and terbutaline): reminder of the risks from overuse in asthma and to be aware of changes in the SABA prescribing guidelines
- Kaftrio▼ (Ivacaftor, tezacaftor, elexacaftor): risk of psychological side effects
- Topiramate (Topamax): introduction of new safety measures, including a Pregnancy Prevention Programme
- Quinine: not to be used routinely for nocturnal leg cramps
- Finasteride: reminder of the risk psychiatric side effects and of sexual side effects (which may persist after discontinuation of treatment)
- Prolonged-release opioids: Removal of indication for relief of post-operative pain
- Over-the-counter painkillers containing codeine or dihydrocodeine
- Methotrexate: advise patients to take precautions in the sun to avoid photosensitivity reactions